why choose us

First received: March 24, 2026

Clinical Trial: Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Neovascular (Wet) Age-Related Macular Degeneration
Retinal Vein Occlusion
Diabetic Macular

Study Type: INTERVENTIONAL


Official Title: An Evaluation of the Clinical Usability of the SCD411 Prefilled Syringe as a Proposed Biosimilar to US-licensed Eylea®

Brief Summary: This is a single-arm, multicenter study to evaluate clinical usability of a pre-filled syringe containing SCD411 in adult patients with neovascular Wet Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), or Diabetic Retinopathy (DR)

Read more